4//SEC Filing
FLUKE JOHN M JR 4
Accession 0001209191-20-051512
CIK 0001620463other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 5:16 PM ET
Size
15.4 KB
Accession
0001209191-20-051512
Insider Transaction Report
Form 4
FLUKE JOHN M JR
Director
Transactions
- Conversion
Common Stock
2020-09-22+6,731→ 6,731 total(indirect: By Fluke Capital Management, L.P.) - Conversion
Common Stock
2020-09-22+12,610→ 63,050 total - Conversion
Common Stock
2020-09-22+51,831→ 114,881 total - Conversion
Series A-1 Preferred Stock
2020-09-22−51,831→ 0 total→ Common Stock (51,831 underlying) - Conversion
Series B-1 Preferred Stock
2020-09-22−6,731→ 0 total(indirect: By Fluke Capital Management, L.P.)→ Common Stock (6,731 underlying) - Conversion
Series A Preferred Stock
2020-09-22−12,610→ 0 total→ Common Stock (12,610 underlying)
Footnotes (3)
- [F1]Each share of Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- [F2]Each share of Series A-1 Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- [F3]Each share of Series B-1 Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001191906
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 5:16 PM ET
- Size
- 15.4 KB